1. Home
  2. RWT vs SCTX Comparison

RWT vs SCTX Comparison

Compare RWT & SCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Redwood Trust Inc.

RWT

Redwood Trust Inc.

HOLD

Current Price

$4.43

Market Cap

597.9M

Sector

Real Estate

ML Signal

HOLD

Logo Scribe Therapeutics Inc. Common Stock

SCTX

Scribe Therapeutics Inc. Common Stock

N/A

Current Price

$30.20

Market Cap

536.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RWT
SCTX
Founded
1994
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
597.9M
536.5M
IPO Year
1996
2026

Fundamental Metrics

Financial Performance
Metric
RWT
SCTX
Price
$4.43
$30.20
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$6.82
N/A
AVG Volume (30 Days)
1.4M
209.7K
Earning Date
04-29-2026
N/A
Dividend Yield
12.83%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$26.59
N/A
Revenue Next Year
$22.21
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.19
$17.31
52 Week High
$6.97
$39.60

Technical Indicators

Market Signals
Indicator
RWT
SCTX
Relative Strength Index (RSI) 33.18 56.22
Support Level $4.19 $19.09
Resistance Level $4.93 $34.64
Average True Range (ATR) 0.10 4.80
MACD -0.02 0.00
Stochastic Oscillator 0.00 52.19

Price Performance

Historical Comparison
RWT
SCTX

About RWT Redwood Trust Inc.

Redwood Trust Inc is a specialty finance company focused on several distinct areas of housing credit. The company delivers customized housing credit investments to a diverse mix of investors through securitization platforms, whole-loan distribution activities, and its publicly traded securities. The company has four reportable segments: Sequoia Mortgage Banking, CoreVest Mortgage Banking, Redwood Investments, and Legacy Investments. Maximum revenue is generated from the Sequoia Mortgage Banking segment, comprising a mortgage loan conduit that acquires residential consumer loans from third-party originators for subsequent sale to whole loan buyers, securitization through its SEMT private-label securitization program, or transfer into its Redwood Investments portfolio.

About SCTX Scribe Therapeutics Inc. Common Stock

Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.

Share on Social Networks: